Clinical Trials Insight: 700039719

Trial Profile

Clinical Trials Insight: 700039719

Phase of Trial: Phase I

Latest Information Update: 15 Dec 2009

At a glance

  • Drugs Caplacizumab (Primary)
  • Indications Thrombosis; Thrombotic thrombocytopenic purpura
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Ablynx
  • Most Recent Events

    • 15 Dec 2009 Results presented at the 51st Annual Meeting and Exposition of the American Society of Hematology (ASH 2009).
    • 19 Aug 2009 Status changed from recruiting to completed, based on results reported in media release.
    • 18 Aug 2009 Positive results data have been reported in an Ablynx media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top